ArticleFrontiers in surgery2026
Case Report: Intravascular lithotripsy combined with a new-generation 3-in-1 carotid stent for calcified carotid artery stenosis.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Symptomatic carotid atherosclerotic stenosis is a major cause of ischemic stroke. In patients with heavily calcified plaque and limited physiologic reserve for open revascularization, conventional carotid artery stenting may fail because rigid calcium prevents adequate luminal expansion. Intravascular lithotripsy (IVL) is an adjunctive plaque-modification strategy for selected calcified carotid lesions, although evidence remains limited and carotid IVL is investigational. Case presentation: An 83-year-old man with hyperlipidemia, hypertension, hypothyroidism, protein S deficiency, prior myocardial infarction, and lower-extremity deep vein thrombosis on apixaban presented with acute ischemic stroke manifested by dysarthria, global aphasia, and right hemiparesis. Brain MRI showed acute left-hemisphere borderzone infarcts involving deep white matter and basal ganglia, consistent with ipsilateral carotid atheroembolism and/or relative hypoperfusion. CTA and cerebral angiography demonstrated approximately 60% left internal carotid artery stenosis, with heavy concentric calcification spanning a lesion length greater than 10 mm at the carotid bifurcation. Management and outcome: After multidisciplinary review of carotid endarterectomy, TCAR, and transfemoral options, IVL-assisted carotid angioplasty and stenting under continuous embolic protection was selected given advanced age, prior myocardial infarction, acute neurologic impairment, and limited functional reserve. Using distal embolic protection and proximal balloon-guide flow arrest, IVL was performed across the calcified plaque, followed by deployment of a new-generation integrated 3-in-1 carotid stent. Angiographic stenosis improved from approximately 60% to approximately 20% by NASCET methodology without periprocedural stroke, vasospasm, dissection, hemodynamic instability, or access-site complication. Admission NIHSS was 29; discharge NIHSS and mRS were 6 and 3, respectively. At approximately 1-month follow-up he was alert and oriented ×3 with fluent language and good comprehension. No further antithrombotic regimen switch occurred during outpatient follow-up, and no perioperative complications were reported. Conclusion: In this elderly patient with acute ischemic stroke and heavily calcified symptomatic carotid stenosis, IVL with angioplasty and a 3-in-1 carotid stent achieved early technical success without periprocedural complication and with short-term clinical stability. This case supports further investigation of IVL-based carotid revascularization in carefully selected patients who are poor candidates for open surgery and highlights the need for standardized follow-up, neurologic outcome reporting, and prospective evaluation of long-term patency and stroke prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.